FDA Alerts
FDA Alerts
10/11/2016
The FDA has approved a quadrivalent formulation of Flublok influenza vaccine, which protects against 4 strains of influenza.
10/11/2016
FDA Alerts
FDA Alerts
10/11/2016
The FDA has approved a quadrivalent formulation of Flublok influenza vaccine, which protects against 4 strains of influenza.
10/11/2016
FDA Alerts
FDA Alerts
10/06/2016
The FDA has approved Zubsolv (buprenorphine/naloxone CIII sublingual tablets) 0.7mg/0.18mg for the treatment of patients with opioid dependence.
10/06/2016
FDA Alerts
FDA Alerts
10/06/2016
The FDA has approved Zubsolv (buprenorphine/naloxone CIII sublingual tablets) 0.7mg/0.18mg for the treatment of patients with opioid dependence.
10/06/2016
FDA Alerts
FDA Alerts
10/06/2016
The FDA has approved Zubsolv (buprenorphine/naloxone CIII sublingual tablets) 0.7mg/0.18mg for the treatment of patients with opioid dependence.
10/06/2016
FDA Alerts
FDA Alerts
10/04/2016
The US Food and Drug Administration is now requiring a Boxed Warning be added to the drug labels of certain direct-acting antiviral medicines used for the treatment of hepatitis C.
10/04/2016
FDA
FDA
10/03/2016
The FDA issued a statement regarding serious adverse events with homeopathic teething tablets and gels.
10/03/2016
FDA
FDA
10/03/2016
The FDA issued a statement regarding serious adverse events with homeopathic teething tablets and gels.
10/03/2016
FDA
FDA
10/03/2016
The FDA issued a statement regarding serious adverse events with homeopathic teething tablets and gels.
10/03/2016
FDA Alerts
FDA Alerts
09/30/2016
The FDA approved a system to automatically monitor glucose and administer basal insulin doses in individuals aged 14 and older with type 1 diabetes.
09/30/2016